Cidofovir
Cidofovir.JPG

Cidofovir

CLINICAL USE

Treatment of CMV retinitis in patients with AIDS, if other agents are unsuitableTreatment of BK polyoma virus in transplant patients (unlicensed)

DOSE IN NORMAL RENAL FUNCTION

5 mg/kg weekly for 2 weeks then once every 2 weeks(See further information for BK polyoma virus treatment)

PHARMACOKINETICS

  • Molecular weight                           :279.2
  • %Protein binding                           :<6
  • %Excreted unchanged in urine     : 80–100
  • Volume of distribution (L/kg)       :0.3–0.8
  • half-life – normal/ESRD (hrs)      :1.7–2.7/16–251

    DOSE IN RENAL IMPAIRMENT

    GFR (mL/MIN)

    >55 Dose as in normal renal function<55 Avoid. See ‘Other Information’

    DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

  • CAPD                :Not dialysed. 0.5 mg/kg/dose
  • HD                     :Dialysed. 0.5 mg/kg/dose
  • HDF/high flux   :Dialysed. 0.5 mg/kg/dose
  • CAV/VVHD      :Unknown dialysability. 0.5 mg/kg/dose

    IMPORTANT DRUG INTERACTIONS

    Potentially hazardous interactions with other drugsNone known

    ADMINISTRATION

    Reconstition

    Route

    IV infusion

    Rate of Administration

    Over 60 minutes

    Comments

    Dilute in 100 mL sodium chloride 0.9%

    OTHER INFORMATION

    Always administer with oral probenecid and intravenous sodium chloride 0.9%Administer 2 hours before dialysis session to benefit from peak concentration without having delayed clearance52–75% of dose dialysed out with high- flux haemodialysisInformation for the treatment of BK polyoma virus in transplant patients is from Pittsburgh. Starting dose was 0.25 mg/kg (if GFR<30 mL/min) in 100 mL sodium chloride 0.9% administered over 1 hour, given every 10–14 days. Hydration pre- and post-dose with 1 litre of sodium chloride 0.9% if tolerated. If no change within 10–14 days increase to 0.3–0.5 mg/kg; dose can be increased up to 1 mg/kg depending on response and side effects. Most patients would need a cumulative dose of 1–1.5 mg/kg. Initially use without probenecid. Monitor blood and urine samples for PCR measurement of viral load. The manufacturer advises to avoid in renal failure but theoretical doses, based on a 70 kg person, are suggested in the following paper



    See how to identify renal failure stages according to GFR calculation

    See how to diagnose irreversible renal disease

    Home

  • other drugs